Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Development of models for predicting Torsade de Pointes cardiac arrhythmias using perceptron neural networks

Journal Article · · BMC Bioinformatics
 [1];  [2];  [2];  [2]
  1. U.S. Food and Drug Administration (FDA), Jefferson, AR (United States). National Center for Toxicology Research. Division of Systems Biology; DOE/OSTI
  2. U.S. Food and Drug Administration (FDA), Jefferson, AR (United States). National Center for Toxicology Research. Division of Systems Biology
Background: Blockage of some ion channels and in particular, the hERG (human Ether-a’-go-go-Related Gene) cardiac potassium channel delays cardiac repolarization and can induce arrhythmia. In some cases it leads to a potentially life-threatening arrhythmia known as Torsade de Pointes (TdP). Therefore recognizing drugs with TdP risk is essential. Candidate drugs that are determined not to cause cardiac ion channel blockage are more likely to pass successfully through clinical phases II and III trials (and preclinical work) and not be withdrawn even later from the marketplace due to cardiotoxic effects. The objective of the present study is to develop an SAR (Structure-Activity Relationship) model that can be used as an early screen for torsadogenic (causing TdP arrhythmias) potential in drug candidates. The method is performed using descriptors comprised of atomic NMR chemical shifts (13C and 15N NMR) and corresponding interatomic distances which are combined into a 3D abstract space matrix. The method is called 3D-SDAR (3-dimensional spectral data-activity relationship) and can be interrogated to identify molecular features responsible for the activity, which can in turn yield simplified hERG toxicophores. A dataset of 55 hERG potassium channel inhibitors collected from Kramer et al. consisting of 32 drugs with TdP risk and 23 with no TdP risk was used for training the 3D-SDAR model. Results: An artificial neural network (ANN) with multilayer perceptron was used to define collinearities among the independent 3D-SDAR features. A composite model from 200 random iterations with 25% of the molecules in each case yielded the following figures of merit: training, 99.2%; internal test sets, 66.7%; external (blind validation) test set, 68. 4%. In the external test set, 70.3% of positive TdP drugs were correctly predicted. Moreover, toxicophores were generated from TdP drugs. Conclusion: A 3D-SDAR was successfully used to build a predictive model for drug-induced torsadogenic and non-torsadogenic drugs based on 55 compounds. The model was tested in 38 external drugs.
Research Organization:
Oak Ridge Institute for Science and Education (ORISE), Oak Ridge, TN (United States)
Sponsoring Organization:
USDOE Office of Science (SC)
Grant/Contract Number:
SC0014664
OSTI ID:
1626766
Journal Information:
BMC Bioinformatics, Journal Name: BMC Bioinformatics Journal Issue: S14 Vol. 18; ISSN 1471-2105
Publisher:
BioMed CentralCopyright Statement
Country of Publication:
United States
Language:
English

References (37)

Torsades de Pointes Occurring in Association With Terfenadine Use journal December 1990
QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system journal November 2005
Alignment-independent technique for 3D QSAR analysis journal March 2016
Dealing with Global Safety Issues: Was the Response to QT-Liability of Non-Cardiac Drugs Well Coordinated? journal February 2013
Computational investigations of hERG channel blockers: New insights and current predictive models journal June 2015
Contribution of voltage-gated potassium channels to the regulation of apoptosis journal January 2010
Computational approaches to understand the adverse drug effect on potassium, sodium and calcium channels for predicting TdP cardiac arrhythmias journal September 2017
Structure and function of two-pore-domain K channels: contributions from genetic model organisms journal July 2005
Hose — a novel substructure code journal December 1978
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development journal April 2003
Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches journal May 2003
Experimentally Validated hERG Pharmacophore Models as Cardiotoxicity Prediction Tools journal September 2014
Voltage-gated potassium channels as therapeutic targets journal December 2009
Cisapride and Fatal Arrhythmia journal July 1996
Simulation of multiple ion channel block provides improved early prediction of compounds’ clinical torsadogenic risk journal February 2011
The Utility of hERG and Repolarization Assays in Evaluating Delayed Cardiac Repolarization: Influence of Multi-Channel Block journal January 2004
Three-Dimensional Quantitative Structure-Activity Relationship for Inhibition of Human Ether-a-Go-Go -Related Gene Potassium Channel journal May 2002
Drug induced QT prolongation and torsades de pointes journal November 2003
Cardiac Ion Channels journal April 2009
Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death journal November 2001
In Silico Predictions of hERG Channel Blockers in Drug Discovery: From Ligand-Based and Target-Based Approaches to Systems Chemical Biology journal June 2011
Torsades de pointes occurring in association with terfenadine use journal December 1990
Torsades de pointes occurring in association with terfenadine use journal November 1991
A Composite Model for hERG Blockade journal February 2008
Using Neural Networks for 13C NMR Chemical Shift Prediction–Comparison with Traditional Methods journal August 2002
Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic journal July 2020
Hose — a novel substructure code journal December 1978
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development journal April 2003
Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches journal May 2003
3D-SDAR modeling of hERG potassium channel affinity: A case study in model design and toxicophore identification journal March 2017
Methadone—metabolism, pharmacokinetics and interactions journal December 2004
Predicting drug–hERG channel interactions that cause acquired long QT syndrome journal March 2005
MICE Models: Superior to the HERG Model in Predicting Torsade de Pointes journal July 2013
Cisapride and Fatal Arrhythmia journal July 1996
Cardiac Ion Channels journal April 1993
Cardiac ion channels journal July 2015
Cardiac Ion Channels journal April 2009

Cited By (2)

Synthesis and Biological Evaluation of Five‐Atom‐Linker‐Based Arylpiperazine Derivatives with an Atypical Antipsychotic Profile journal November 2019
Comparison of Machine Learning Techniques for Prediction of Hospitalization in Heart Failure Patients journal August 2019